The Opioid Epidemic continues to evolve across the country. Synthetic opioids (fentanyl) have been the main cause of rising overdose deaths. The approach to treatment of Opioid Use Disorder (OUD) is multidisciplinary. Evidence-based pharmacologic treatments have been available for many years but access to appropriate care is limited. In this presentation the pharmacology of the FDA approved Medications for OUD will be reviewed along with the unique challenges, regulations, monitoring parameters, and access for each. Common barriers faced by patients seeking care and clinicians providing care will be reviewed including the significant effect of stigma.
After completion of this course, the participant will be able to:
3.0 CE’s Offered:
Samuel K. Parish, MD, FASAM